About Synlogic Therapeutics
Synlogic Therapeutics is a company based in Cambridge (United States) founded in 2013 by James J Collins.. Synlogic Therapeutics has raised $34.4 million across 9 funding rounds from investors including Gates Foundation, HHS and Orbimed. The company has 1 employees as of December 31, 2024. Synlogic Therapeutics offers products and services including Synthetic Biotics. Synlogic Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Amyris and Rhythm Pharmaceuticals, among others.
- Headquarter Cambridge, United States
- Employees 1 as on 31 Dec, 2024
- Founders James J Collins
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synlogic, Inc.
-
Annual Revenue
$8 K-99.76as on Dec 31, 2024
-
Net Profit
$-23.36 M61.88as on Dec 31, 2024
-
EBITDA
$-14.48 M70.96as on Dec 31, 2024
-
Total Equity Funding
$34.4 M (USD)
in 9 rounds
-
Latest Funding Round
$80 M (USD), Post-IPO
Jun 18, 2019
-
Investors
Gates Foundation
& 11 more
-
Employee Count
1
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Synlogic Therapeutics
Synlogic Therapeutics is a publicly listed company on the NASDAQ with ticker symbol SYBX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Synlogic Therapeutics
Synlogic Therapeutics offers a comprehensive portfolio of products and services, including Synthetic Biotics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineered microbes to treat metabolic diseases like PKU.
Unlock access to complete
Funding Insights of Synlogic Therapeutics
Synlogic Therapeutics has successfully raised a total of $34.4M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $80 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $80.0M
-
First Round
First Round
(01 Jul 2013)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2019 | Amount | Post-IPO - Synlogic Therapeutics | Valuation |
investors |
|
| May, 2017 | Amount | Post-IPO - Synlogic Therapeutics | Valuation |
investors |
|
| Feb, 2016 | Amount | Post-IPO - Synlogic Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Synlogic Therapeutics
Synlogic Therapeutics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Gates Foundation, HHS and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment, VC & financial advisory firm
|
Founded Year | Domain | Location | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
VC Firm investing in geographies such as the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Synlogic Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Synlogic Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synlogic Therapeutics Comparisons
Competitors of Synlogic Therapeutics
Synlogic Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Amyris and Rhythm Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synlogic Therapeutics
Frequently Asked Questions about Synlogic Therapeutics
When was Synlogic Therapeutics founded?
Synlogic Therapeutics was founded in 2013.
Where is Synlogic Therapeutics located?
Synlogic Therapeutics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Synlogic Therapeutics a funded company?
Synlogic Therapeutics is a funded company, having raised a total of $34.4M across 9 funding rounds to date. The company's 1st funding round was a Post-IPO of $40M, raised on Jul 01, 2013.
How many employees does Synlogic Therapeutics have?
As of Dec 31, 2024, the latest employee count at Synlogic Therapeutics is 1.
What is the annual revenue of Synlogic Therapeutics?
Annual revenue of Synlogic Therapeutics is $8K as on Dec 31, 2024.
What does Synlogic Therapeutics do?
Synlogic Therapeutics was founded in 2013 in Cambridge, Massachusetts, within the biotechnology sector. A proprietary platform is employed to engineer microbes for drug production, targeting urea cycle disorders and phenylketonuria. Standardized interchangeable parts and gene-circuit controls are integrated to design synthetic biology solutions. Microbes are transformed into symbiotic living therapeutics that respond to pathophysiological signals in the human body, facilitating targeted treatments.
Who are the top competitors of Synlogic Therapeutics?
Synlogic Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Synlogic Therapeutics offer?
Synlogic Therapeutics offers Synthetic Biotics.
Is Synlogic Therapeutics publicly traded?
Yes, Synlogic Therapeutics is publicly traded on NASDAQ under the ticker symbol SYBX.
Who are Synlogic Therapeutics's investors?
Synlogic Therapeutics has 12 investors. Key investors include Gates Foundation, HHS, Orbimed, Atlas Venture, and Perceptive Advisors.
What is Synlogic Therapeutics's ticker symbol?
The ticker symbol of Synlogic Therapeutics is SYBX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.